Intravitreal injection of ranibizumab in severe retinopathy of incontinentia pigmenti.
暂无分享,去创建一个
Peiquan Zhao | K. Xue | Xin Huang | Lu Ruan | Jia Yu | Yingqin Ni | Jie Peng
[1] A. Young,et al. SUCCESSFUL TREATMENT OF REFRACTORY PROLIFERATIVE RETINOPATHY OF INCONTINENTIA PIGMENTI BY INTRAVITREAL RANIBIZUMAB AS ADJUNCT THERAPY IN A 4-YEAR-OLD CHILD , 2016, Retinal cases & brief reports.
[2] H. Quiroz-Mercado,et al. Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity , 2012, British Journal of Ophthalmology.
[3] Anna L. Ells,et al. Are we there yet? Bevacizumab therapy for retinopathy of prematurity , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.
[4] Alice Z Chuang,et al. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. , 2011, The New England journal of medicine.
[5] S. Bressler. Introduction: Understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration. , 2009, Ophthalmology.
[6] X. Katz,et al. ZONE I RETINOPATHY OF PREMATURITY: Clinical Characteristics and Treatment Outcomes , 2006, Retina.
[7] J. Nguyen,et al. Laser photocoagulation in preproliferative retinopathy of incontinentia pigmenti. , 2001, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[8] W. Tasman,et al. Treatment of proliferative retinopathy associated with incontinentia pigmenti. , 1990, American journal of ophthalmology.
[9] M. Goldberg. The blinding mechanisms of incontinentia pigmenti. , 1994, Ophthalmic genetics.